Omrix Biopharmaceuticals Inc
|
630 5th Avenue, 22nd Floor
New York, NY 10111
USA
United States |
| Tel: |
1/212 887-6550 |
| URL: |
http://www.omrix.com |
|
 |
| Primary Symbols & Exchanges: |
| OMRI - NASDAQ |
| - Berlin-Bremen Stock Exchange |
|
|
| Primary Industry: |
| Biotechnology |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Groups' principal activities are to develop and market innovative biological products. The Group utilizes proprietary protein purification technology and manufacturing know-how to develop biosurgical and passive immunotherapy products. Its biosurgical product line includes products and product candidates that are used for hemostasis and other surgical applications. Its passive immunotherapy product line includes antibody-rich products and product candidates for the treatment of immune deficiencies and infectious diseases, including potential biodefense applications. The Group operates in the United States, Europe and Israel. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Omrix Biopharmaceuticals Inc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
